Proton beam therapy aims to zap prostate cancer with fewer side effects
NCT ID NCT01950351
First seen Jan 05, 2026 · Last updated Jun 16, 2026 · Updated 28 times
Summary
This study tests a type of radiation called hypofractionated proton beam therapy for men with early-stage prostate cancer that hasn't spread. The goal is to see if giving higher doses of radiation in fewer sessions can kill cancer cells while causing less damage to healthy tissue. About 241 men will take part, and researchers will track side effects and quality of life over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I PROSTATE ADENOCARCINOMA AJCC V7 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.